These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6615848)

  • 1. Identification of a contaminant protein in the purification of human factor V. Comparison of two purification methods.
    Bruin T; Ockelford P; ten Cate JW; Sturk A; Breederveld C
    Biochim Biophys Acta; 1983 Oct; 748(1):139-42. PubMed ID: 6615848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation and properties of factor V from bovine plasma.
    Chulkova T; Hernandez G
    Clin Chim Acta; 1975 Jul; 62(1):21-8. PubMed ID: 1149279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular changes associated with proteolysis of bovine factor V by thrombin.
    Kandall CL; Rosenberg R; Colman RW
    Eur J Biochem; 1975 Oct; 58(1):203-11. PubMed ID: 1183435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of human coagulation factor V.
    Kane WH; Majerus PW
    J Biol Chem; 1981 Jan; 256(2):1002-7. PubMed ID: 7451453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat coagulation factor V purification and production of the monospecific antiserum.
    Cornillon B; Paul J; Mazzorana M; Belleville J
    Comp Biochem Physiol B; 1986; 83(2):397-401. PubMed ID: 3956160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and partial characterization of human factor V.
    Bolhuis PA; Hakvoort TB; Breederveld K; Mochtar IA; ten Cate JW
    Biochim Biophys Acta; 1979 May; 578(1):23-30. PubMed ID: 454668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
    Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V.
    Kalafatis M; Krishnaswamy S; Rand MD; Mann KG
    Methods Enzymol; 1993; 222():224-36. PubMed ID: 8412796
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemical studies on factor V.
    Greenquist AC; Weinberg RM; Kuo AL; Colman RW
    Eur J Biochem; 1975 Oct; 58(1):213-22. PubMed ID: 810349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fractionation of factor V from human plasma.
    Giddings JC
    Thromb Diath Haemorrh; 1974 Jun; 31(3):457-68. PubMed ID: 4420496
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of human alpha 1-beta glycoprotein and study of its microheterogeneity and molecular variants.
    Miribel L; Arnaud P
    J Chromatogr; 1987 Sep; 405():337-45. PubMed ID: 2447112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved procedure for the purification of selenoprotein Ph from human plasma.
    Eberle B; Haas HJ
    J Trace Elem Med Biol; 1995 Mar; 9(1):55-7. PubMed ID: 8846159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment.
    Gounaris AD; Brown MA; Barrett AJ
    Biochem J; 1984 Jul; 221(2):445-52. PubMed ID: 6548132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin.
    Dahlbäck B
    Biochem J; 1983 Mar; 209(3):837-46. PubMed ID: 6223624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step purification of d(-)-specific carbamoylase from Agrobacterium tumefaciens AM 10.
    Sareen D; Sharma R; Nandanwar HS; Vohra RM
    Protein Expr Purif; 2001 Feb; 21(1):170-5. PubMed ID: 11162403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.
    Lebreton JP; Joisel F; Raoult JP; Lannuzel B; Rogez JP; Humbert G
    J Clin Invest; 1979 Oct; 64(4):1118-29. PubMed ID: 90057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.
    Chiu HC; Whitaker E; Colman RW
    J Clin Invest; 1983 Aug; 72(2):493-503. PubMed ID: 6348091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of selenoprotein Ph from human plasma.
    Eberle B; Haas HJ
    J Trace Elem Electrolytes Health Dis; 1993 Dec; 7(4):217-21. PubMed ID: 8019151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of the high molecular form of bovine factor X and some of its physical properties.
    Yue RH; Gertler MM
    Biochim Biophys Acta; 1977 Feb; 490(2):350-62. PubMed ID: 836878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.